106 related articles for article (PubMed ID: 4032233)
1. [Pharmaceutical evaluation of a hollow type suppository. III. Effect of macrogol 300 on the bioavailability of indomethacin in rabbits].
Watanabe Y; Tone Y; Suzuki M; Matsumoto M
Yakugaku Zasshi; 1985 Mar; 105(3):284-8. PubMed ID: 4032233
[No Abstract] [Full Text] [Related]
2. Medicament release from suppository bases I: Physicochemical characteristics and bioavailability of indomethacin in rabbits.
Vidras NJ; Reid VE; Bohidar NR; Plakogiannis FM
J Pharm Sci; 1982 Aug; 71(8):945-9. PubMed ID: 7120104
[TBL] [Abstract][Full Text] [Related]
3. [Pharmaceutical evaluation of a hollow type suppository. II. Indomethacin added form and release characteristics of the hollow type suppository].
Watanabe Y; Yokoyama K; Yamaji M; Tanaka F; Matsumoto M
Yakugaku Zasshi; 1985 Mar; 105(3):278-83. PubMed ID: 4032232
[No Abstract] [Full Text] [Related]
4. Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits.
Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K
Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2999-3004. PubMed ID: 3769103
[No Abstract] [Full Text] [Related]
5. Effect of the molecular weight of polyethylene glycol on the bioavailability of indomethacin sustained-release suppositories prepared with solid dispersions.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3511-5. PubMed ID: 3427728
[No Abstract] [Full Text] [Related]
6. Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories.
Umeda T; Matsuzawa A; Yokoyama T; Kuroda K; Kuroda T
Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2793-8. PubMed ID: 6652823
[No Abstract] [Full Text] [Related]
7. Pharmaceutical evaluation of hollow type suppositories. IV. Improvement of bioavailability of propranolol in rabbits after rectal administration.
Watanabe Y; Matsumoto Y; Baba K; Matsumoto M
J Pharmacobiodyn; 1986 Jun; 9(6):526-31. PubMed ID: 3761140
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical evaluation of hollow type suppositories. V. Preparation of valproic acid suppository and rectal absorption of valproic acid in rabbits.
Watanabe Y; Tone Y; Nishihara S; Matsumoto M
J Pharmacobiodyn; 1986 Dec; 9(12):953-61. PubMed ID: 3106614
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetic comparison of two indometacin containing suppositories with different vehicula.
Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A
Arzneimittelforschung; 1984; 34(4):523-5. PubMed ID: 6547611
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of indomethacin sustained-release suppositories using a hydroxypropylmethylcellulose acetate succinate-polyethylene glycol 2000 solid matrix.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3935-9. PubMed ID: 3435990
[No Abstract] [Full Text] [Related]
12. Difference in rectal absorption of morphine from hollow-type and conventional suppositories in rabbits.
Matsumoto Y; Watanabe Y; Yamamoto I; Matsumoto M
Biol Pharm Bull; 1993 Feb; 16(2):150-3. PubMed ID: 8364450
[TBL] [Abstract][Full Text] [Related]
13. Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Furuya A; Koishi M
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4249-54. PubMed ID: 3435949
[No Abstract] [Full Text] [Related]
14. [Biopharmaceutical evaluation of the rectal application of mefenamic acid. I. Study of the suppositories prepared on hydrophilic bases].
Kosiar A
Acta Pol Pharm; 1983; 40(1):105-9. PubMed ID: 6880815
[No Abstract] [Full Text] [Related]
15. Bioavailability of indomethacin after intramuscular injection and rectal administration of solution and suppositories.
Jensen KM; Grenabo L
Acta Pharmacol Toxicol (Copenh); 1985 Nov; 57(5):322-7. PubMed ID: 4090993
[TBL] [Abstract][Full Text] [Related]
16. Influence of macrogol bases on the bioavailability of bacampicillin after rectal administration in rabbits.
Kawashima S; Nakazawa H; Fujiwara H
Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1475-82. PubMed ID: 3416367
[No Abstract] [Full Text] [Related]
17. [Pharmaceutical evaluation of hollow type suppository. I. Brilliant blue FCF release characteristics of oleaginous hollow type suppository].
Watanabe Y; Matsumoto M
Yakugaku Zasshi; 1984 May; 104(5):479-84. PubMed ID: 6491887
[No Abstract] [Full Text] [Related]
18. Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin.
Miyazaki S; Yokouchi C; Nakamura T; Hashiguchi N; Hou WM; Takada M
Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1801-8. PubMed ID: 3719880
[No Abstract] [Full Text] [Related]
19. Evaluation of indomethacin sustained-release suppositories prepared with a methacrylic acid-methacrylic acid methyl ester copolymer-polyethylene glycol 2000 solid matrix.
Ohnishi N; Yokoyama T; Kiyohara Y; Okumura K; Kuroda K
Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):430-4. PubMed ID: 3378304
[No Abstract] [Full Text] [Related]
20. Studies of pharmacokinetics of indomethacin in man under consideration of bioavailability.
Hippius M; Reinicke C
Agents Actions Suppl; 1982; 10():109-17. PubMed ID: 6956211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
